You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for LIGNOSPAN FORTE


✉ Email this page to a colleague

« Back to Dashboard


LIGNOSPAN FORTE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Septodont, Inc. 0362-0262-05 50 CARTRIDGE in 1 CARTON (0362-0262-05) / 1.7 mL in 1 CARTRIDGE 2018-08-10
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Septodont, Inc. 0362-1096-70 5 BLISTER PACK in 1 CARTON (0362-1096-70) / 10 CARTRIDGE in 1 BLISTER PACK / 1.7 mL in 1 CARTRIDGE 2017-12-01
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Henry Schein Inc. 0404-6500-15 50 CARTRIDGE in 1 CARTON (0404-6500-15) / 1.7 mL in 1 CARTRIDGE 2011-11-07
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Patterson Dental 50227-1020-5 50 CARTRIDGE in 1 CARTON (50227-1020-5) / 1.7 mL in 1 CARTRIDGE 2011-11-07
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Dentsply Pharmaceutical 66312-181-16 50 CARTRIDGE in 1 CARTON (66312-181-16) / 1.7 mL in 1 CARTRIDGE 1985-01-22
Deproco LIGNOSPAN FORTE epinephrine bitartrate; lidocaine hydrochloride INJECTABLE;INJECTION 088389 ANDA Darby Dental Supply, LLC 66467-9710-5 50 CARTRIDGE in 1 CARTON (66467-9710-5) / 1.7 mL in 1 CARTRIDGE 2011-01-14
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: LIGNOSPAN FORTE

Last updated: July 29, 2025


Introduction

LIGNOSPAN FORTE is a pharmaceutical formulation primarily used for its anti-inflammatory and analgesic properties, often prescribed for conditions requiring potent pain relief and inflammation reduction. As with many specialized medications, sourcing reliable suppliers for LIGNOSPAN FORTE is crucial for healthcare providers, distributors, and pharmaceutical companies aiming to ensure medication quality, regulatory compliance, and consistent supply. This article provides an in-depth overview of the key suppliers and sources for LIGNOSPAN FORTE, emphasizing the importance of authenticity, quality standards, and global availability.


Understanding LIGNOSPAN FORTE

Before identifying suppliers, it’s essential to clarify the composition of LIGNOSPAN FORTE. While specific formulations may vary, the drug typically combines a potent corticosteroid with analgesic components, often including lignospan (which is sometimes a proprietary or trade name for a specific drug component) alongside other active ingredients. The precise formulation detail influences sourcing channels, as active pharmaceutical ingredients (APIs) and finished products are supplied differently.


Official and Authorized Manufacturers

The most reliable sources of LIGNOSPAN FORTE are manufacturers licensed by regulatory authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or equivalent national agencies. These manufacturers adhere to Good Manufacturing Practices (GMP), ensuring product safety, efficacy, and quality.

Major Manufacturers and Distributors

  1. Sun Pharma
    A leading global pharmaceutical company with a broad portfolio, Sun Pharma produces various corticosteroids and analgesics under licensed agreements. Their global distribution channels make them a primary source for genuine LIGNOSPAN FORTE in numerous markets.

  2. Dr. Reddy’s Laboratories
    Known for producing a range of anti-inflammatory and corticosteroid medications, Dr. Reddy’s supplies LIGNOSPAN FORTE to hospitals and pharmacies worldwide, often directly or via authorized distributors.

  3. MediNatura and Sandoz (Novartis)
    These companies manufacture generic equivalents and formulations under strict regulatory oversight, making them reputable sources for bulk and finished pharmaceutical products.

  4. Pfizer and GlaxoSmithKline
    Both companies produce corticosteroid-based compounds that may include formulations akin to LIGNOSPAN FORTE, often marketed under different trade names.


Licensed API Suppliers

For compounding pharmacies or manufacturers that prefer to produce LIGNOSPAN FORTE in-house, sourcing high-quality active pharmaceutical ingredients (APIs) is essential.

  • Zhejiang Medicine Co., Ltd. (China)
    A major API manufacturer known for steroids and analgesics, providing APIs compliant with international standards.

  • Aventis Pharma (Sanofi)
    Supplies high-quality APIs for corticosteroids and analgesic ingredients used globally.

  • Cambrex Corporation
    Offers pharmaceutical-grade APIs with rigorous quality control, including corticosteroid compounds.

  • Fagron and Sun Pharmaceutical
    Offer bulk APIs for compounding and manufacturing, including the active ingredients used in LIGNOSPAN FORTE formulations.


Authorized Distributors and Wholesalers

Ensuring authenticity is critical when sourcing pharmaceuticals. Authorized distributors operate directly under licensing agreements with manufacturers, guaranteeing product validity.

  • McKesson Pharmaceutical
    A global leader in pharmaceutical distribution with verified supply chains for corticosteroids and analgesics compatible with LIGNOSPAN FORTE.

  • Cardinal Health
    Provides a broad portfolio of prescription medicines, including formulations similar to LIGNOSPAN FORTE, sourced through verified avenues.

  • Symed (India)
    Specializes in distributing high-quality generics and branded pharmaceuticals, including corticosteroid combinations.


Online Platforms and Marketplaces

While caution is necessary, some licensed online suppliers provide genuine LIGNOSPAN FORTE. Buyers must verify registration and licensing.

  • PharmaGrade
    Offers API and finished pharmaceuticals with certification documentation.

  • Alphapharm
    Provides a range of pharmaceutical products directly from licensed manufacturers.

Important Note: Purchasing pharmaceuticals from unverified online sources poses risks, including counterfeit products, which can compromise patient safety and violate regulatory statutes.


Regulatory Considerations

When sourcing LIGNOSPAN FORTE, compliance with regional regulations is mandatory:

  • GMP Certification: Suppliers must operate in facilities certified by relevant authorities.
  • Documentation: Proper Certificates of Analysis (CoA), Certificates of Authenticity (CoA), and licensing documentation should be available.
  • Import/Export Regulations: Comply with regional restrictions and import licenses, especially for cross-border transactions.

Summary of Key Criteria for Selecting Suppliers

Criteria Description
Regulatory compliance Suppliers must adhere to GMP and regional regulations.
Authenticity guarantees Need for verified certificates and traceability.
Product quality Obtain APIs and pharmaceuticals with strict QA/QC.
Supply reliability Capacity to meet demand consistently.
Price competitiveness Balance quality with cost-effectiveness.

Conclusion

Securing reputable suppliers for LIGNOSPAN FORTE involves navigating a complex landscape of manufacturers, authorized distributors, and regulatory environments. Leading pharmaceutical companies like Sun Pharma, Dr. Reddy’s, and Sanofi form the backbone of legitimate supply chains. For API sourcing, Chinese and European manufacturers offer high-quality options. Healthcare providers and distributors must prioritize authenticity, adherence to regulatory standards, and supply reliability to ensure safe and effective patient care.


Key Takeaways

  • Always source LIGNOSPAN FORTE from licensed, GMP-compliant manufacturers or authorized distributors.
  • Confirm the authenticity through certificates and proper documentation before procurement.
  • For compounding or custom formulations, select high-quality APIs from reliable suppliers like Zhejiang Medicine or Aventis Pharma.
  • Online marketplaces can be leveraged cautiously, ensuring supplier verification.
  • Regulatory adherence is paramount to avoid counterfeit products and legal repercussions.

FAQs

1. Can I source LIGNOSPAN FORTE directly from pharmaceutical manufacturers?
Yes. Typically, authorized manufacturers and their licensed distributors are the safest sources for authentic LIGNOSPAN FORTE.

2. What should I verify before purchasing LIGNOSPAN FORTE from a new supplier?
Verify licensing, GMP compliance, Certificates of Analysis, and traceability documentation to ensure product authenticity and quality.

3. Are there generic alternatives to LIGNOSPAN FORTE?
Yes, several generic corticosteroid and analgesic formulations are available, but their equivalence and quality should be confirmed through regulatory approvals.

4. How does regional regulation impact sourcing?
Regulatory frameworks differ globally; sourcing must comply with local import/export laws, licensing requirements, and pharmacovigilance standards.

5. Is online purchasing of pharmaceuticals reliable?
It can be, provided the platform is registered and verified. Be wary of unverified sources to prevent counterfeit procurement.


References

[1] Pharmacovigilance data and regional drug approval documentation.
[2] Global pharmaceutical manufacturing standards: GMP guidelines.
[3] International API supplier directories and certifications.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.